Indian Patent Office rejects J&J’s plea to extend monopoly on bedaquiline, MSF lauds move EP News Bureau Mar 24, 2023 J&J must not block the supply of more affordable generic versions of bedaquiline to high TB burden countries and stand by its…
Bajaj Healthcare applies to Indian patent office for compulsory licence for Baricitinib Press Trust of India Jun 29, 2021 Considering Bajaj Healthcare's manufacturing capabilities and strong in-house R&D team, we can produce Baricitinib at very…
Venus Remedies wins battle against SCR Pharmatop to revoke Indian patent for IV paracetamol EP News Bureau Jun 18, 2021 Venus Remedies challenged the Indian patent by the French pharmaceutical giant SCR Pharmatop in 2011 after prompted by an…
Indian Patent office issues new guidelines for pharmaceutical patent applications EP News Bureau Nov 3, 2014 Generic disclosure in the prior art may not necessarily take away the novelty of a specific disclosure